Internal Medicine, Rheumatology · Boca Raton, FL
NPI
1144323023
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1050 NW 15th St, Suite 212a
Boca Raton, FL, 33486
Phone (561) 368-5611
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.4M
217,629 services
Medicare patients, 2024
1,216
Average age 78
Drug cost, 2024
$979K
2,381 prescriptions
Company payments, 2025
$3,171
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph Z Forstot was code J3111 (injection, romosozumab-aqqg, 1 mg), 52,920 times for 104 patients. In total Joseph Z Forstot billed 217,629 services in 98 codes, and Medicare paid $2.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 52,920 | 104 | $8.54 | $452K |
| J3262 Injection, tocilizumab, 1 mg | Office | 49,388 | 28 | $4.71 | $233K |
| J0897 Injection, denosumab, 1 mg | Office | 35,040 | 473 | $20.68 | $725K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 26,800 | 27 | $3.60 | $96K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 17,752 | 115 | $0.10 | $1,838 |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 10,600 | 24 | $9.07 | $96K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 8,325 | 34 | $33.88 | $282K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,920 | 13 | $25.04 | $73K |
| 96401 Chemotherapy Administration | Office | 1,252 | 603 | $56.83 | $71K |
| 99214 Office E&M - Established | Office | 1,037 | 360 | $94.71 | $98K |
| 99213 Office E&M - Established | Office | 1,031 | 491 | $67.93 | $70K |
| 36415 Venipuncture Blood Collection | Office | 633 | 383 | $8.65 | $5,475 |
| 85025 Blood Count | Office | 592 | 364 | $7.61 | $4,505 |
| 82565 Clinical Chemistry | Office | 587 | 365 | $5.02 | $2,947 |
| 84520 Clinical Chemistry | Office | 579 | 359 | $3.87 | $2,241 |
By year: 2022 $2.5M for 186,864 services; 2023 $2.1M for 169,326 services; 2024 $2.4M for 217,629 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 633 | 383 | $8.65 | $5,475 |
| 85025 Blood Count | 592 | 364 | $7.61 | $4,505 |
| 82565 Clinical Chemistry | 587 | 365 | $5.02 | $2,947 |
| 84520 Clinical Chemistry | 579 | 359 | $3.87 | $2,241 |
| 82310 Clinical Chemistry | 456 | 322 | $5.06 | $2,307 |
| 84080 Clinical Chemistry | 446 | 318 | $14.48 | $6,458 |
| 84100 Clinical Chemistry | 446 | 318 | $4.65 | $2,074 |
| 82306 Clinical Chemistry | 371 | 276 | $29.01 | $11K |
| 83970 Clinical Chemistry | 336 | 243 | $40.45 | $14K |
| 85651 Clinical Chemistry | 303 | 170 | $4.18 | $1,267 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph Z Forstot prescribed most often to Medicare patients was Meloxicam, with 198 prescriptions and refills. In total Joseph Z Forstot wrote 2,381 Medicare prescriptions that cost $979K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Meloxicam Generic | 198 | 279 | 71 | $835 |
| Prednisone Generic | 191 | 266 | 60 | $1,963 |
| Hydroxychloroquine Sulfate Generic | 156 | 238 | 42 | $4,006 |
| Tramadol Hcl Generic | 123 | 125 | 38 | $1,339 |
| Pregabalin Generic | 106 | 152 | 27 | $4,154 |
| Duloxetine Hcl Generic | 79 | 131 | 20 | $1,147 |
| Raloxifene Hcl Generic | 72 | 139 | 20 | $2,500 |
| Etodolac Generic | 59 | 69 | 21 | $2,186 |
| Methylprednisolone Generic | 57 | 57 | 29 | $322 |
| Diclofenac Potassium Generic | 56 | 81 | 20 | $1,496 |
| Gabapentin Generic | 54 | 76 | 12 | $508 |
| Diclofenac Sodium Generic | 50 | 80 | 19 | $1,910 |
| Colchicine Generic | 49 | 92 | 16 | $2,811 |
| Celecoxib Generic | 47 | 63 | 17 | $903 |
| Sulindac Generic | 42 | 52 | 14 | $617 |
Brand drugs: 214 claims; generic drugs: 2,155 claims; opioid claims: 355.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph Z Forstot $3,171 ($3,171 in general payments such as food, travel and fees) from 22 companies. The largest payer was Janssen Biotech, Inc. with $575.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 21 | $575 |
| Abbvie Inc. ABBV | 28 | $541 |
| Amgen Inc. AMGN | 27 | $508 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $231 |
| UCB, Inc. UCB.BR | 11 | $230 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $219 |
| Radius Health, Inc. | 7 | $175 |
| Pfizer Inc. PFE | 6 | $104 |
| GlaxoSmithKline, LLC. GSK | 4 | $91.14 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $81.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.